• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

-吡嗪甲酰基取代的氨基酸作为潜在的抗分枝杆菌药物-对映异构体的合成与生物学评价。

-Pyrazinoyl Substituted Amino Acids as Potential Antimycobacterial Agents-The Synthesis and Biological Evaluation of Enantiomers.

机构信息

Charles University, Faculty of Pharmacy in Hradec Králové, Akademika Heyrovského 1203, Hradec Králové, Czech Republic.

University Hospital Hradec Králové, Department of Clinical Microbiology, Sokolská 581, 500 05 Hradec Králové, Czech Republic.

出版信息

Molecules. 2020 Mar 27;25(7):1518. doi: 10.3390/molecules25071518.

DOI:10.3390/molecules25071518
PMID:32230728
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7181131/
Abstract

Tuberculosis is an infectious disease caused by (Mtb), each year causing millions of deaths. In this article, we present the synthesis and biological evaluations of new potential antimycobacterial compounds containing a fragment of the first-line antitubercular drug pyrazinamide (PZA), coupled with methyl or ethyl esters of selected amino acids. The antimicrobial activity was evaluated on a variety of (myco)bacterial strains, including Mtb H37Ra, and fungal strains, including and . Emphasis was placed on the comparison of enantiomer activities. None of the synthesized compounds showed any significant activity against fungal strains, and their antibacterial activities were also low, the best minimum inhibitory concentration (MIC) value was 31.25 µM. However, several compounds presented high activity against Mtb. Overall, higher activity was seen in derivatives containing ʟ-amino acids. Similarly, the activity seems tied to the more lipophilic compounds. The most active derivative contained phenylglycine moiety (PC-ᴅ/ʟ-Pgl-Me, MIC < 1.95 µg/mL). All active compounds possessed low cytotoxicity and good selectivity towards Mtb. To the best of our knowledge, this is the first study comparing the activities of the ᴅ- and ʟ-amino acid derivatives of pyrazinamide as potential antimycobacterial compounds.

摘要

结核病是一种由结核分枝杆菌(Mtb)引起的传染病,每年导致数百万人死亡。在本文中,我们合成并评估了一些新的潜在抗分枝杆菌化合物,这些化合物含有一线抗结核药物吡嗪酰胺(PZA)的片段,并与选定氨基酸的甲酯或乙酯相连。我们评估了这些化合物对各种(分枝杆菌)细菌株,包括结核分枝杆菌 H37Ra,以及真菌株,包括 和 的抗菌活性。重点比较了对映异构体的活性。所合成的化合物均对真菌株没有显示出任何显著的活性,其抗菌活性也较低,最佳最小抑菌浓度(MIC)值为 31.25 µM。然而,有几种化合物对结核分枝杆菌表现出很高的活性。总体而言,含 L-氨基酸的衍生物表现出更高的活性。同样,活性似乎与更亲脂性的化合物有关。最活跃的衍生物含有苯甘氨酸部分(PC-ᴅ/ʟ-Pgl-Me,MIC < 1.95 µg/mL)。所有活性化合物均具有低细胞毒性和对结核分枝杆菌的良好选择性。据我们所知,这是首次比较吡嗪酰胺的 D-和 L-氨基酸衍生物作为潜在抗分枝杆菌化合物的活性的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4666/7181131/b725b75e32d0/molecules-25-01518-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4666/7181131/fbdff313a9f9/molecules-25-01518-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4666/7181131/5ede9e519e42/molecules-25-01518-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4666/7181131/b725b75e32d0/molecules-25-01518-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4666/7181131/fbdff313a9f9/molecules-25-01518-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4666/7181131/5ede9e519e42/molecules-25-01518-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4666/7181131/b725b75e32d0/molecules-25-01518-g003.jpg

相似文献

1
-Pyrazinoyl Substituted Amino Acids as Potential Antimycobacterial Agents-The Synthesis and Biological Evaluation of Enantiomers.-吡嗪甲酰基取代的氨基酸作为潜在的抗分枝杆菌药物-对映异构体的合成与生物学评价。
Molecules. 2020 Mar 27;25(7):1518. doi: 10.3390/molecules25071518.
2
N-pyridinylbenzamides: an isosteric approach towards new antimycobacterial compounds.N-吡啶基苯甲酰胺:一种新型抗分枝杆菌化合物的等排体方法。
Chem Biol Drug Des. 2021 Mar;97(3):686-700. doi: 10.1111/cbdd.13804. Epub 2020 Nov 2.
3
Alkylamino derivatives of pyrazinamide: synthesis and antimycobacterial evaluation.吡嗪酰胺的烷基氨基衍生物:合成与抗分枝杆菌活性评价。
Bioorg Med Chem Lett. 2014 Jan 15;24(2):450-3. doi: 10.1016/j.bmcl.2013.12.054. Epub 2013 Dec 19.
4
5-Alkylamino--phenylpyrazine-2-carboxamides: Design, Preparation, and Antimycobacterial Evaluation.5-(烷氨基)-苯并吡嗪-2-甲酰胺:设计、制备与抗分枝杆菌活性评价。
Molecules. 2020 Mar 28;25(7):1561. doi: 10.3390/molecules25071561.
5
Evaluation and Docking Study of Pyrazine Containing 1, 3, 4-Oxadiazoles Clubbed with Substituted Azetidin-2-one: A New Class of Potential Antimicrobial and Antitubercular.含吡嗪的 1,3,4-恶二唑与取代的氮杂环丁酮的组合的评估和对接研究:一类新的潜在抗菌和抗结核药物。
Drug Res (Stuttg). 2021 Jan;71(1):26-35. doi: 10.1055/a-1252-2378. Epub 2020 Oct 7.
6
Synthesis and antimycobacterial activity of N'-[(E)-(monosubstituted-benzylidene)]-2-pyrazinecarbohydrazide derivatives.N'-[(E)-(单取代苄叉基)]-2-吡嗪甲酰肼衍生物的合成及抗分枝杆菌活性。
Eur J Med Chem. 2009 Dec;44(12):4954-9. doi: 10.1016/j.ejmech.2009.08.009. Epub 2009 Sep 1.
7
Synthesis and antimycobacterial evaluation of N-substituted 3-aminopyrazine-2,5-dicarbonitriles.N-取代 3-氨基吡嗪-2,5-二甲腈的合成及抗分枝杆菌活性评价。
Bioorg Med Chem Lett. 2012 Feb 15;22(4):1598-601. doi: 10.1016/j.bmcl.2011.12.129. Epub 2012 Jan 3.
8
Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide.可能影响结核分枝杆菌对吡嗪酰胺药敏试验结果的情况。
J Med Microbiol. 2002 Jan;51(1):42-49. doi: 10.1099/0022-1317-51-1-42.
9
Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide.酸性pH值和吡嗪酸外排缺陷在结核分枝杆菌对吡嗪酰胺独特易感性中的作用
J Bacteriol. 1999 Apr;181(7):2044-9. doi: 10.1128/JB.181.7.2044-2049.1999.
10
Ureidopyrazine Derivatives: Synthesis and Biological Evaluation as Anti-Infectives and Abiotic Elicitors.脲嘧啶并吡嗪衍生物的合成及其作为抗感染和非生物诱导剂的生物评价。
Molecules. 2017 Oct 23;22(10):1797. doi: 10.3390/molecules22101797.

引用本文的文献

1
Improving Antimicrobial Activity and Physico-Chemical Properties by Isosteric Replacement of 2-Aminothiazole with 2-Aminooxazole.通过用2-氨基恶唑等排取代2-氨基噻唑提高抗菌活性和理化性质
Pharmaceuticals (Basel). 2022 May 6;15(5):580. doi: 10.3390/ph15050580.
2
Synthesis, Biological Evaluation, and In Silico Modeling of -Substituted Quinoxaline-2-Carboxamides.β-取代喹喔啉-2-甲酰胺的合成、生物学评价及计算机模拟
Pharmaceuticals (Basel). 2021 Aug 4;14(8):768. doi: 10.3390/ph14080768.

本文引用的文献

1
Synthesis, computational studies, antimycobacterial and antibacterial properties of pyrazinoic acid-isoniazid hybrid conjugates.吡嗪酸-异烟肼杂合共轭物的合成、计算研究、抗分枝杆菌及抗菌性能
RSC Adv. 2019 Jul 1;9(35):20450-20462. doi: 10.1039/c9ra03380g. eCollection 2019 Jun 25.
2
ATP-binding cassette (ABC) import systems of : target for drug and vaccine development.三磷酸腺苷结合盒(ABC)转运蛋白家族:药物和疫苗开发的靶点。
Emerg Microbes Infect. 2020 Jan 27;9(1):207-220. doi: 10.1080/22221751.2020.1714488. eCollection 2020.
3
The molecular basis of pyrazinamide activity on Mycobacterium tuberculosis PanD.
结核分枝杆菌泛二氢蝶酸合成酶的吡嗪酰胺作用的分子基础
Nat Commun. 2020 Jan 17;11(1):339. doi: 10.1038/s41467-019-14238-3.
4
Pyrazinoic Acid Inhibits the Bifunctional Enzyme (Rv2783) in by Competing with tmRNA.吡嗪酸通过与转移信使核糖核酸(tmRNA)竞争来抑制结核分枝杆菌中的双功能酶(Rv2783)。
Pathogens. 2019 Nov 12;8(4):230. doi: 10.3390/pathogens8040230.
5
Pharmacological and Molecular Mechanisms Behind the Sterilizing Activity of Pyrazinamide.吡嗪酰胺杀菌活性的药理学和分子机制。
Trends Pharmacol Sci. 2019 Dec;40(12):930-940. doi: 10.1016/j.tips.2019.10.005. Epub 2019 Nov 6.
6
Comparing the Metabolic Capabilities of Bacteria in the Complex.比较复杂环境中细菌的代谢能力。
Microorganisms. 2019 Jun 18;7(6):177. doi: 10.3390/microorganisms7060177.
7
Flexible nitrogen utilisation by the metabolic generalist pathogen .代谢广谱性病原体对氮的灵活利用
Elife. 2019 Jan 31;8:e41129. doi: 10.7554/eLife.41129.
8
Microbial esterases and ester prodrugs: An unlikely marriage for combating antibiotic resistance.微生物酯酶和酯前药:对抗抗生素耐药性的一种不太可能的结合。
Drug Dev Res. 2019 Feb;80(1):33-47. doi: 10.1002/ddr.21468. Epub 2018 Oct 10.
9
Amino Acids in the Development of Prodrugs.氨基酸在前药开发中的作用。
Molecules. 2018 Sep 11;23(9):2318. doi: 10.3390/molecules23092318.
10
Design, synthesis and antimycobacterial activity of hybrid molecules combining pyrazinamide with a 4-phenylthiazol-2-amine scaffold.将吡嗪酰胺与4-苯基噻唑-2-胺骨架相结合的杂化分子的设计、合成及抗分枝杆菌活性
Medchemcomm. 2018 Feb 22;9(4):685-696. doi: 10.1039/c8md00056e. eCollection 2018 Apr 1.